Fortis Malar Hospitals Limited (Ticker: FORTISMLR.BO) operates as a healthcare provider in India, focusing on multi-specialty hospital services including cardiology, neurology, orthopedics, gastroenterology, oncology, nephrology, and critical care; it offers diagnostic services such as laboratory testing, imaging, and pathology, alongside outpatient consultations, inpatient treatment, and surgical procedures across its facilities. The company, founded in 1993 and headquartered in Chennai, Tamil Nadu, primarily serves patients in southern India through its flagship 180-bed hospital in Adyar, Chennai, with operations concentrated in urban and semi-urban regions of Tamil Nadu and neighboring states. Fortis Malar targets individual patients, corporate clients, and insurance providers in the private healthcare segment, competing in India's growing hospital industry valued for advanced tertiary care. In recent developments within the last two years, the company has pursued operational enhancements amid the Fortis Healthcare group's portfolio optimization, including facility upgrades and digital health integrations to expand telemedicine and patient management services; it reported steady revenue growth from increased occupancy and new specialty programs in 2024-2025, without major acquisitions or name changes noted publicly.